Skip to content

Cliniques de l'Europe - Europa Ziekenhuizen

Active
Non-profit associationfounded 198640 yrs activeDe Frélaan 206, 1180 Ukkel, BelgiumKBO/BCE: BE 0432.011.571
Summary

Cliniques de l'Europe - Europa Ziekenhuizen has been active since 1986 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €139.76M and a net result of €5.04M. Equity remains stable across the filed fiscal years (±0.9% per year). Its solvency ranks better than 39% of 2344 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Cliniques de l'Europe - Europa ZiekenhuizenActiveChecked score 73/100

Checked score

Score 2025
Axes · tick = 2024
Profitability62▲+1
Solvency72▲+1
Growth51▼-1
Track record100
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2M at 30 days acceptable
Liquidity tight (current ratio 1.16 against 1.03 in 2024; short-term debt: 29.8% and cash: 3.7% of total assets), and 53.4% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 40 years 0 50 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
46.6%
Return on assets
1.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
18 d early
2024
27 d early
2023
12 d early
2022
21 d early
2021
24 d early
2020
29 d early
2019
25 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Turnover
€332.46M▲ 3.0%
2024 · €322.68M
2018: €240.49Mlowest value 2019: €254.35M▲ +5.8% vs 2018 2021: €271.07M 2022: €287.03M▲ +5.9% vs 2021 2023: €306.74M▲ +6.9% vs 2022 2024: €322.68M▲ +5.2% vs 2023 2025: €332.46M▲ +3.0% vs 2024highest value
2018 → 2025
EBIT margin
-0.6%▲ 0.2pp
2024 · -0.8%
2018: -0.4% 2019: 0.2%▲ +158% vs 2018highest value 2021: -0.6% 2022: -0.8%▼ -17.9% vs 2021 2023: -0.9%▼ -23.9% vs 2022lowest value 2024: -0.8%▲ +15.2% vs 2023 2025: -0.6%▲ +25.2% vs 2024
2018 → 2025
Net result
€5.04M▲ 50.7%
2024 · €3.34M
2018: €6.72Mhighest value 2019: €4.38M▼ -34.8% vs 2018 2021: €4.82M 2022: €106k▼ -97.8% vs 2021lowest value 2023: €922k▲ +772% vs 2022 2024: €3.34M▲ +263% vs 2023 2025: €5.04M▲ +50.7% vs 2024
2018 → 2025
Working capital
€13.96M▲ 530%
2024 · €2.22M
2018: €-1.60M 2019: €-4.53M▼ -183% vs 2018lowest value 2021: €4.61M 2022: €1.48M▼ -67.8% vs 2021 2023: €3.51M▲ +136% vs 2022 2024: €2.22M▼ -36.8% vs 2023 2025: €13.96M▲ +530% vs 2024highest value
2018 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€271.07M-€287.03M▲ 5.9%€306.74M▲ 6.9%€322.68M▲ 5.2%€332.46M▲ 3.0% 2021: €271.07Mlowest in 5 years 2022: €287.03M▲ +5.9% vs 2021 2023: €306.74M▲ +6.9% vs 2022 2024: €322.68M▲ +5.2% vs 2023 2025: €332.46M▲ +3.0% vs 2024highest in 5 years
Equity€134.96M-€133.57M▼ 1.0%€132.78M▼ 0.6%€134.28M▲ 1.1%€139.76M▲ 4.1% 2021: €134.96M 2022: €133.57M▼ -1.0% vs 2021 2023: €132.78M▼ -0.6% vs 2022lowest in 5 years 2024: €134.28M▲ +1.1% vs 2023 2025: €139.76M▲ +4.1% vs 2024highest in 5 years
Operating result€-1.74M-€-2.17M▼ 24.8%€-2.87M▼ 32.4%€-2.56M▲ 10.8%€-1.97M▲ 23.0% 2021: €-1.74Mhighest in 5 years 2022: €-2.17M▼ -24.8% vs 2021 2023: €-2.87M▼ -32.4% vs 2022lowest in 5 years 2024: €-2.56M▲ +10.8% vs 2023 2025: €-1.97M▲ +23.0% vs 2024
Net result€4.82M-€106k▼ 97.8%€922k▲ 772%€3.34M▲ 263%€5.04M▲ 50.7% 2021: €4.82M 2022: €106k▼ -97.8% vs 2021lowest in 5 years 2023: €922k▲ +772% vs 2022 2024: €3.34M▲ +263% vs 2023 2025: €5.04M▲ +50.7% vs 2024highest in 5 years
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€-4.00M€-2.00M€0€2.00M€4.00M€6.00MOperating result 2021: €-1.74M€-1.74MNet result 2021: €4.82M€4.82MOperating result 2022: €-2.17M€-2.17MNet result 2022: €106k€106kOperating result 2023: €-2.87M€-2.87MNet result 2023: €922k€922kOperating result 2024: €-2.56M€-2.56MNet result 2024: €3.34M€3.34MOperating result 2025: €-1.97M€-1.97MNet result 2025: €5.04M€5.04M20212022202320242025€-4M€-2M€0€2M€4M€6MOperating result 2023: €-2.87M€-2.9MNet result 2023: €922k€922kOperating result 2024: €-2.56M€-2.6MNet result 2024: €3.34M€3.3MOperating result 2025: €-1.97M€-2MNet result 2025: €5.04M€5M202320242025
The operating result stays negative: a loss of €1.97M in 2025 against €2.56M in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €300.23M
Fixed assets €196.93M ▼ 1.9%
Current assets €103.31M ▲ 16.1%
Equity and liabilities €300.23M
Equity €139.76M ▲ 4.1%
Provisions €6.63M ▼ 0.8%
Debt €153.84M ▲ 3.3%
Debt's share of the balance-sheet total falls from 51.4% to 51.2%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€20.37M▲
2024 · €18.95M
Cash flow
€27.37M▲
2024 · €24.86M
Current ratio
1.16▲
2024 · 1.03
Quick ratio
1.10▲
2024 · 0.98
Debt to equity
1.10▼
2024 · 1.11
ROE
3.6%▲
2024 · 2.5%
ROA
1.7%▲
2024 · 1.2%
Interest coverage
11.90▲
2024 · 11.37
Debt ≤ 1 year
€89.35M▲
2024 · €86.78M
Debt > 1 year
€62.07M▲
2024 · €61.20M
Staff costs
€129.83M▲
2024 · €126.06M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 81 lines
Balance sheet Code20242025
Assets
Total assets20/58€289.83M€300.23M▲
Formation expenses20€0€0▲
Fixed assets21/28€200.83M€196.93M▼
Intangible fixed assets21€267k€340k▲
Tangible fixed assets22/27€200.55M€196.57M▼
Land and buildings22€158.21M€160.79M▲
Plant, machinery and equipment23€26.85M€24.04M▼
Furniture and vehicles24€10.92M€10.08M▼
Assets under construction and advance payments27€4.56M€1.66M▼
Financial fixed assets28€18k€18k=
Other financial fixed assets284/8€18k€18k=
Amounts receivable and cash guarantees285/8€18k€18k=
Current assets29/58€89.00M€103.31M▲
Amounts receivable after more than one year29€2€2=
Other amounts receivable291€2€2=
Stocks and contracts in progress3€3.95M€4.61M▲
Stocks30/36€3.95M€4.61M▲
Raw materials and consumables30/31€3.95M€4.61M▲
Amounts receivable within one year40/41€78.56M€85.00M▲
Trade receivables40€76.76M€82.57M▲
Other amounts receivable41€1.80M€2.43M▲
Current investments50/53€35k€35k=
Cash at bank and in hand54/58€4.19M€11.01M▲
Deferred charges and accrued income490/1€2.26M€2.65M▲
Equity and liabilities
Total equity and liabilities10/49€289.83M€300.23M▲
Equity10/15€134.28M€139.76M▲
Contributions10/11€4.91M€4.91M=
Capital10€4.91M€4.91M=
Reserves13€7.79M€9.50M▲
Profit (loss) carried forward14€46.46M€49.78M▲
Investment grants15€75.12M€75.57M▲
Provisions and deferred taxes16€6.69M€6.63M▼
Provisions for liabilities and charges160/5€6.69M€6.63M▼
Pensions and similar obligations160€269k€246k▼
Other liabilities and charges164/5€6.42M€6.38M▼
Amounts payable17/49€148.87M€153.84M▲
Amounts payable after more than one year17€61.20M€62.07M▲
Financial debts170/4€50.42M€56.11M▲
Credit institutions173€50.42M€56.11M▲
Other amounts payable178/9€10.79M€5.97M▼
Amounts payable within one year42/48€86.78M€89.35M▲
Current portion of amounts payable after more than one year42€5.15M€5.59M▲
Trade debts44€62.68M€63.42M▲
Suppliers440/4€62.68M€63.42M▲
Taxes, remuneration and social security45€14.77M€15.33M▲
Taxes450/3€548k€516k▼
Remuneration and social security454/9€14.22M€14.81M▲
Accrued charges and deferred income492/3€881k€2.42M▲
Income statement Code20242025
Operating income70/76A€344.62M€355.28M▲
Turnover70€322.68M€332.46M▲
Own construction capitalised72€459k€525k▲
Other operating income74€21.46M€22.28M▲
Non-recurring operating income76A€23k€15k▼
Operating charges60/66A€347.18M€357.25M▲
Goods for resale, raw materials and consumables60€63.15M€64.40M▲
Purchases600/8€62.84M€65.09M▲
Change in stocks: decrease (increase)609€318k€-686k▼
Services and other goods61€134.45M€139.58M▲
Remuneration, social security and pensions62€126.06M€129.83M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€21.51M€22.34M▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€1.99M€792k▼
Other operating charges640/8€463k€347k▼
Non-recurring operating charges66A€18k€24k▲
Operating profit (loss)9901€-2.56M€-1.97M▲
Financial income75/76B€9.17M€9.52M▲
Recurring financial income75€2.40M€2.39M▼
Income from current assets751€135k€82k▼
Other financial income752/9€2.27M€2.31M▲
Non-recurring financial income76B€6.76M€7.13M▲
Financial charges65/66B€3.26M€2.51M▼
Recurring financial charges65€1.81M€1.81M▼
Debt charges650€1.67M€1.71M▲
Other financial charges652/9€141k€94k▼
Non-recurring financial charges66B€1.46M€707k▼
Profit (loss) for the period before taxes9903€3.34M€5.04M▲
Profit (loss) for the period9904€3.34M€5.04M▲
Profit (loss) for the period to be appropriated9905€3.34M€5.04M▲
Appropriation of the result
Profit (loss) to be appropriated9906€47.44M€51.49M▲
Profit (loss) brought forward from the previous period14P€44.09M€46.46M▲
To contributions691€978k€1.71M▲
Social balance
Average headcount (FTE)90871,573.01,577.0▲

The notes to these accounts (81 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement
Line20212022202320242025Change
Operating income70/76A€284.91M€304.64M€328.64M€344.62M€355.28M▲ 3.1%
Turnover70€271.07M€287.03M€306.74M€322.68M€332.46M▲ 3.0%
Own construction capitalised72€366k€489k€397k€459k€525k▲ 14.4%
Other operating income74€13.38M€17.09M€21.49M€21.46M€22.28M▲ 3.9%
Non-recurring operating income76A€95k€28k€19k€23k€15k▼ 37.8%
Operating charges60/66A€286.64M€306.80M€331.51M€347.18M€357.25M▲ 2.9%
Goods for resale, raw materials and consumables60€56.67M€57.72M€63.28M€63.15M€64.40M▲ 2.0%
Purchases600/8€57.06M€57.63M€63.62M€62.84M€65.09M▲ 3.6%
Change in stocks: decrease (increase)609€-391k€87k€-343k€318k€-686k▼ 316%
Services and other goods61€112.09M€116.11M€123.11M€134.45M€139.58M▲ 3.8%
Remuneration, social security and pensions62€95.01M€113.68M€121.68M€126.06M€129.83M▲ 3.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€19.97M€19.64M€21.69M€21.51M€22.34M▲ 3.8%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€600k€988k€1.08M€1.99M€792k▼ 60.3%
Other operating charges640/8€328k€336k€340k€463k€347k▼ 25.0%
Non-recurring operating charges66A€126k€16k€19k€18k€24k▲ 32.0%
Operating profit (loss)9901€-1.74M€-2.17M€-2.87M€-2.56M€-1.97M▲ 23.0%
Financial income75/76B€8.35M€3.71M€6.20M€9.17M€9.52M▲ 3.9%
Recurring financial income75€2.28M€2.27M€2.31M€2.40M€2.39M▼ 0.5%
Income from current assets751--€48k€135k€82k▼ 39.0%
Other financial income752/9€2.28M€2.27M€2.26M€2.27M€2.31M▲ 1.8%
Non-recurring financial income76B€6.08M€1.44M€3.89M€6.76M€7.13M▲ 5.4%
Financial charges65/66B€1.80M€1.43M€2.41M€3.26M€2.51M▼ 23.0%
Recurring financial charges65€1.34M€1.36M€1.66M€1.81M€1.81M▼ 0.1%
Debt charges650€1.22M€1.24M€1.53M€1.67M€1.71M▲ 2.7%
Other financial charges652/9€116k€124k€135k€141k€94k▼ 33.2%
Non-recurring financial charges66B€462k€73k€750k€1.46M€707k▼ 51.4%
Profit (loss) for the period before taxes9903€4.82M€106k€922k€3.34M€5.04M▲ 50.7%
Profit (loss) for the period9904€4.82M€106k€922k€3.34M€5.04M▲ 50.7%
Profit (loss) for the period to be appropriated9905€4.82M€106k€922k€3.34M€5.04M▲ 50.7%
Line20212022202320242025Change
Assets
Total assets20/58€284.04M€288.78M€293.79M€289.83M€300.23M▲ 3.6%
Formation expenses20€244k€143k€41k€0€0-
Fixed assets21/28€188.48M€202.27M€201.51M€200.83M€196.93M▼ 1.9%
Intangible fixed assets21€1.36M€645k€380k€267k€340k▲ 27.4%
Tangible fixed assets22/27€187.10M€201.61M€201.11M€200.55M€196.57M▼ 2.0%
Land and buildings22€151.45M€160.43M€157.79M€158.21M€160.79M▲ 1.6%
Plant, machinery and equipment23€19.71M€27.83M€29.44M€26.85M€24.04M▼ 10.5%
Furniture and vehicles24€10.57M€10.63M€10.07M€10.92M€10.08M▼ 7.7%
Assets under construction and advance payments27€5.37M€2.72M€3.80M€4.56M€1.66M▼ 63.7%
Financial fixed assets28€18k€18k€18k€18k€18k=
Other financial fixed assets284/8€18k€18k€18k€18k€18k=
Amounts receivable and cash guarantees285/8€18k€18k€18k€18k€18k=
Current assets29/58€95.32M€86.36M€92.24M€89.00M€103.31M▲ 16.1%
Amounts receivable after more than one year29€2€2€2€2€2=
Other amounts receivable291€2€2€2€2€2=
Stocks and contracts in progress3€4.01M€3.93M€4.27M€3.95M€4.61M▲ 16.7%
Stocks30/36€4.01M€3.93M€4.27M€3.95M€4.61M▲ 16.7%
Raw materials and consumables30/31€4.01M€3.93M€4.27M€3.95M€4.61M▲ 16.7%
Amounts receivable within one year40/41€70.61M€69.10M€73.16M€78.56M€85.00M▲ 8.2%
Trade receivables40€68.77M€67.29M€71.87M€76.76M€82.57M▲ 7.6%
Other amounts receivable41€1.84M€1.81M€1.29M€1.80M€2.43M▲ 35.1%
Current investments50/53€35k€35k€35k€35k€35k=
Cash at bank and in hand54/58€18.77M€11.52M€12.91M€4.19M€11.01M▲ 162%
Deferred charges and accrued income490/1€1.90M€1.78M€1.87M€2.26M€2.65M▲ 17.3%
Equity and liabilities
Total equity and liabilities10/49€284.04M€288.78M€293.79M€289.83M€300.23M▲ 3.6%
Equity10/15€134.96M€133.57M€132.78M€134.28M€139.76M▲ 4.1%
Contributions10/11---€4.91M€4.91M=
Capital10---€4.91M€4.91M=
Reserves13€10.98M€8.45M€6.81M€7.79M€9.50M▲ 22.0%
Profit (loss) carried forward14€38.90M€41.53M€44.09M€46.46M€49.78M▲ 7.2%
Investment grants15€80.18M€78.68M€76.97M€75.12M€75.57M▲ 0.6%
Provisions and deferred taxes16€8.51M€6.83M€7.16M€6.69M€6.63M▼ 0.8%
Provisions for liabilities and charges160/5€8.51M€6.83M€7.16M€6.69M€6.63M▼ 0.8%
Pensions and similar obligations160€579k€458k€332k€269k€246k▼ 8.5%
Other liabilities and charges164/5€7.93M€6.38M€6.83M€6.42M€6.38M▼ 0.5%
Amounts payable17/49€140.57M€148.37M€153.86M€148.87M€153.84M▲ 3.3%
Amounts payable after more than one year17€47.58M€61.90M€64.23M€61.20M€62.07M▲ 1.4%
Financial debts170/4€43.03M€48.03M€49.19M€50.42M€56.11M▲ 11.3%
Credit institutions173€43.03M€48.03M€49.19M€50.42M€56.11M▲ 11.3%
Other amounts payable178/9€4.55M€13.87M€15.04M€10.79M€5.97M▼ 44.7%
Amounts payable within one year42/48€90.72M€84.88M€88.73M€86.78M€89.35M▲ 3.0%
Current portion of amounts payable after more than one year42€4.61M€5.31M€5.34M€5.15M€5.59M▲ 8.6%
Trade debts44€71.16M€63.65M€64.61M€62.68M€63.42M▲ 1.2%
Suppliers440/4€71.16M€63.65M€64.61M€62.68M€63.42M▲ 1.2%
Advances received on contracts in progress46€10k€2k----
Taxes, remuneration and social security45€12.17M€13.62M€16.13M€14.77M€15.33M▲ 3.8%
Taxes450/3€786k€851k€638k€548k€516k▼ 5.8%
Remuneration and social security454/9€11.38M€12.77M€15.49M€14.22M€14.81M▲ 4.1%
Accrued charges and deferred income492/3€2.28M€1.60M€888k€881k€2.42M▲ 175%
Line20212022202320242025Change
Profit (loss) for the period9904€4.82M€106k€922k€3.34M€5.04M▲ 50.7%
+ Depreciation and write-downs630€19.97M€19.64M€21.69M€21.51M€22.34M▲ 3.8%
Operating cash flow (approximation)€24.79M€19.74M€22.61M€24.86M€27.37M▲ 10.1%
Investment in fixed assets (approximation)-€-33.43M€-20.93M€-20.84M€-18.43M▲ 11.5%
Change in cash-€-7.24M€1.38M€-8.71M€6.81M▲ 178%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Sign in to download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
18-08
State Gazette act Resignation: Dokter Jan Benijts, Uroloog (director)
Appointment: Jan Benijts (director) · Registered-office move5 facts ▸
  • General meeting, 05-02-2026
  • Board meeting, 30-01-2026
  • Director resignation, Dokter Jan Benijts, Uroloog (director)
  • Director appointment, Jan Benijts (director)
  • Registered-office move, Sparredreef 12, 8490 Jabbeke (Varsenare)
13-07
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
25-11
State Gazette act Reappointment: Yombi Jean Cyr (director)
Appointment: Gorgemans Arnaud (director) · Resignation: Dolphens Mieke (director) · Permanent representative: P. Fontaine6 facts ▸
  • General meeting, 26-06-2025
  • Board meeting, 26-06-2025
  • Director reappointment, Yombi Jean Cyr (director)
  • Director appointment, Gorgemans Arnaud (director)
  • Director resignation, Dolphens Mieke (director)
  • Permanent representative, P. Fontaine
04-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
05-05
State Gazette act Resignations: Godin Jean-Noël (director) and Verlinde Caroline (director)
Appointment: Callens, Vandelanotte & Theunissen SRL (statutory auditor) · Permanent representatives: Lieven Van Brussel and Ahmed Fourati · Statutes amendment8 facts ▸
  • General meeting, 16-12-2024
  • Statutes amendment
  • Director resignation, Godin Jean-Noël (director)
  • Director resignation, Verlinde Caroline (director)
  • General meeting, 24-06-2024
  • Auditor appointment, Callens, Vandelanotte & Theunissen SRL
  • Permanent representative, Lieven Van Brussel
  • Permanent representative, Ahmed Fourati
2024
19-07
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
02-05
State Gazette act Resignation: BV BVDL (afgevaardigd bestuurder en medisch directeur)
Reappointments: Verlinde Caroline, Godin Jean-Noël and BV Dr. Jan BENIJTS · Permanent representatives: Vandeleene Bernard, Dr BENIJTS Jan and Sebastian Spencer · Appointment: BV SEBASTIAN SPENCER EMERGENCY CARE SYSTEMS (medisch directeur en afgevaardigd bestuurder & bestuurder)10 facts ▸
  • General meeting, 18-12-2023
  • Director resignation, BV BVDL (afgevaardigd bestuurder en medisch directeur)
  • Director reappointment, Verlinde Caroline (director)
  • Director reappointment, Godin Jean-Noël (director)
  • Director reappointment, BV Dr. Jan BENIJTS (director)
  • Permanent representative, Vandeleene Bernard
  • Permanent representative, Dr BENIJTS Jan
  • General meeting, 18-12-2023
  • Director appointment, BV SEBASTIAN SPENCER EMERGENCY CARE SYSTEMS (medisch directeur en afgevaardigd bestuurder & bestuurder)
  • Permanent representative, Sebastian Spencer
2023
13-10
State Gazette act Appointments: VZW Dokter Jan Benijts, Uroloog, NV SMA and 5 others
Permanent representatives: Benijts Jan, van Lierde Bruno and 2 others · Resignation: BVBA ADAX 68 (director) · Power of attorney19 facts ▸
  • General meeting, 16-12-2019
  • Director appointment, VZW Dokter Jan Benijts, Uroloog (director)
  • Permanent representative, Benijts Jan
  • General meeting, 11-07-2022
  • Director appointment, NV SMA (director)
  • Permanent representative, van Lierde Bruno
  • General meeting, 24-06-2022
  • Director appointment, vzw Qaly-Co (director)
  • Permanent representative, Verplancke Lieve
  • Director appointment, GREGOIRE Donatienne (director)
  • Director appointment, WELTENS Caroline (director)
  • Director appointment, DE LEYN Paul (director)
  • +7 further facts in this act
10-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
22-02
State Gazette act Appointments: BDO, LAMBRECHT Philippe and MUSTIN Vincent
Statutes amendment7 facts ▸
  • General meeting, 28/06/2021
  • Statutes amendment
  • Auditor appointment, BDO (statutory auditor)
  • General meeting, 24/06/2022
  • Board meeting, 20/06/2022
  • Director appointment, LAMBRECHT Philippe (director)
  • Director appointment, MUSTIN Vincent (director)
2022
31-12
Financial Weakest financial yearnet €106k ▼97.8%
Net result drops to €106k, the lowest in the series; recovery starts the following year.
07-07
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
Show earlier events
03-03
State Gazette act Resignation: Vandeleene Bernard (medisch directeur en afgevaardigd bestuurder)
Appointment: BV BVDL (medisch directeur en afgevaardigd bestuurder) · Permanent representative: Vandeleene Bernard5 facts ▸
  • General meeting, 28-06-2021
  • Board meeting, 28-06-2021
  • Director resignation, Vandeleene Bernard (medisch directeur en afgevaardigd bestuurder)
  • Director appointment, BV BVDL (medisch directeur en afgevaardigd bestuurder)
  • Permanent representative, Vandeleene Bernard
2021
06-09
State Gazette act Appointments: Dolphens Mieke, Yombi Jean Cyr and Vandeleene Bernard
6 facts ▸
  • General meeting, 12-04-2021
  • Director appointment, Dolphens Mieke (director)
  • Director appointment, Yombi Jean Cyr (director)
  • Board meeting, 22-03-2021
  • Director appointment, Vandeleene Bernard (medisch directeur)
  • Director appointment, Vandeleene Bernard (afgevaardigd bestuurder)
02-07
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
24-12
State Gazette act Resignation: SCINTIMAG (afgevaardig bestuurder)
Permanent representative: Meeûs d'Argenteuil Yvan · Appointment: Vandeleene Bernard (medisch directeur ad interim)6 facts ▸
  • Board meeting, 06-07-2020
  • General meeting, 06-07-2020
  • Director resignation, SCINTIMAG (afgevaardig bestuurder)
  • Permanent representative, Meeûs d'Argenteuil Yvan
  • Director appointment, Vandeleene Bernard (medisch directeur ad interim)
  • Permanent representative, Meeûs d'Argenteuil Yvan
06-07
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
05-03
State Gazette act Resignation: Axler Adrienne (director)
Appointments: BVBA ADAX 68, Godin Jean-Noël and 2 others · Permanent representative: Axler Adrienne · Statutes amendment11 facts ▸
  • General meeting, 16-12-2019
  • General meeting, 14-06-2019
  • Board meeting, 16-12-2019
  • Statutes amendment
  • Director resignation, Axler Adrienne (director)
  • Director appointment, BVBA ADAX 68 (director)
  • Permanent representative, Axler Adrienne
  • Director appointment, Godin Jean-Noël (director)
  • Director appointment, Verlinde Caroline (director)
  • Director appointment, van Arenberg Charles-Louis (director)
  • Director appointment, van Arenberg Charles-Louis (vice-chair)
2019
21-06
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
14-06
State Gazette act Resignations: Fontaine Peter, van Lierde Bruno and 4 others
11 facts ▸
  • General meeting, 13-02-2019
  • Director resignation, Fontaine Peter (director)
  • Director resignation, Fontaine Peter (managing director)
  • Director resignation, Fontaine Peter (directeur général)
  • Director resignation, van Lierde Bruno (chair)
  • Director resignation, van Lierde Bruno (director)
  • Director resignation, d' Arenberg Charles-Louis (vice-chair)
  • Director resignation, d' Arenberg Charles-Louis (director)
  • Director resignation, Verplancke Lieve (director)
  • Director resignation, Benijts Jan (director)
  • Director resignation, de Meeus Y. (administrateur délégué unique représentant de la spri scintimag)
14-06
State Gazette act Resignations: Fontaine Peter, VERPLANCKE Lieve and 3 others
7 facts ▸
  • General meeting, 13-02-2019
  • Director resignation, Fontaine Peter (director)
  • Director resignation, VERPLANCKE Lieve (director)
  • Director resignation, Benijts Jan (director)
  • Director resignation, Fontaine Peter (afgevaardigd bestuurder en algemeen directeur)
  • Director resignation, ARENBERG Charles-Louis (vice president en bestuurder)
  • Director resignation, LIERDE Bruno (president en bestuurder)
14-06
State Gazette act Appointments: VZW HSMC (Health System Management & Consult), NV SMA and 3 others
Permanent representatives: Fontaine Peter, van Lierde Bruno and 3 others15 facts ▸
  • Board meeting, 13/02/2019
  • General meeting, 13/02/2019
  • Director appointment, VZW HSMC (Health System Management & Consult) (afgevaardigd bestuurder)
  • Permanent representative, Fontaine Peter
  • Director appointment, NV SMA (president)
  • Permanent representative, van Lierde Bruno
  • Director appointment, NV Forelux (vice president)
  • Permanent representative, van Arenberg Charles-Louis
  • Director appointment, VZW HSMC (Health System Management & Consult) (director)
  • Director appointment, vzw Qaly-Co (director)
  • Permanent representative, Verplancke Lieve
  • Director appointment, VZW Dokter Jan Benijts, Uroloog (director)
  • +3 further facts in this act
2018
07-11
State Gazette act Appointments: van LIERDE Bruno (chair) and d'ARENBERG Charles-Louis (vice-chair)
3 facts ▸
  • Board meeting, 17/09/2018
  • Director appointment, van LIERDE Bruno (chair)
  • Director appointment, d'ARENBERG Charles-Louis (vice-chair)
07-11
State Gazette act Appointments: LIERDE Bruno (chair) and d'ARENBERG Charles-Louis (vice-chair)
3 facts ▸
  • Board meeting, 17-09-2018
  • Director appointment, LIERDE Bruno (chair)
  • Director appointment, d'ARENBERG Charles-Louis (vice-chair)
21-09
State Gazette act Appointment: VAN LIERDE Bruno (a.i. vice voorzitter)
1 fact ▸
  • Director appointment, VAN LIERDE Bruno (a.i. vice voorzitter)
22-08
State Gazette act Resignations: CASTEELS Minne, DURANT Guy and 3 others
Appointments: WELTENS Caroline, GREGOIRE Donatienne and 6 others · Reappointments: HAINE Emmanuel (director) and VERPLANCKE Lieve (director)17 facts ▸
  • General meeting, 08-06-2018
  • Director resignation, CASTEELS Minne (director)
  • Director resignation, DURANT Guy (director)
  • Director resignation, VERHAEGHE Jan (director)
  • Director resignation, MELIN Jacques (director)
  • Director resignation, GERNAY Catherine (director)
  • Director appointment, WELTENS Caroline (director)
  • Director appointment, GREGOIRE Donatienne (director)
  • Director appointment, DE LEYN Paul (director)
  • Director appointment, VANDELEENE Bernard (director)
  • Director appointment, AXLER Adrienne (director)
  • Director reappointment, HAINE Emmanuel (director)
  • +5 further facts in this act
22-06
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
15-05
State Gazette act Resignations: MOSSOUX Jean (director) and DE GREEF Piet (director)
Appointment: van LIERDE Bruno (director)6 facts ▸
  • General meeting, 21-12-2017
  • Director resignation, MOSSOUX Jean (director)
  • Director appointment, van LIERDE Bruno (director)
  • Director appointment, van LIERDE Bruno (afgevaardigd bestuurder)
  • General meeting, 30-05-2016
  • Director resignation, DE GREEF Piet (director)
2017
24-10
State Gazette act Appointment: BVBA SCINTIMAG (director)
Permanent representative: de Meeus d'Argenteuil Yvan5 facts ▸
  • General meeting, 09/06/2017
  • Director appointment, BVBA SCINTIMAG (director)
  • Board meeting, 19/06/2017
  • Director appointment, BVBA SCINTIMAG (afgevaardigd bestuurder)
  • Permanent representative, de Meeus d'Argenteuil Yvan
30-06
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
24-02
State Gazette act Appointments: FONTAINE Peter, GORGEMANS Arnaud and 2 others
Resignations: CASTEELS Minne (chair of the board) and ORAMED bvba (afgevaardigd bestuurder) · Permanent representative: ILUNGA KALENGA Oly12 facts ▸
  • General meeting, 17-10-2016
  • Board meeting, 17-10-2016
  • Director appointment, FONTAINE Peter (director)
  • Director appointment, FONTAINE Peter (afgevaardigd bestuurder)
  • Director appointment, GORGEMANS Arnaud (director)
  • Board meeting, 21-11-2016
  • Director resignation, CASTEELS Minne (chair of the board)
  • Director appointment, DURANT Guy (voorzitter van de raad van bestuur ad interim)
  • Director appointment, van ARENBERG Charles-Louis (chair of the board)
  • Board meeting, 19-12-2016
  • Director resignation, ORAMED bvba (afgevaardigd bestuurder)
  • Permanent representative, ILUNGA KALENGA Oly
2016
16-09
State Gazette act Resignation: JPTR BVBA (afgevaardigd bestuurder, bestuurder en secretaris van de raad van bestuur)
Meeting2 facts ▸
  • Director resignation, JPTR BVBA (afgevaardigd bestuurder, bestuurder en secretaris van de raad van bestuur)
  • Meeting, 20/06/2016
15-03
State Gazette act Resignations: BOSQUET Marc (director) and VANACKERE Steven (director)
Appointments: BENIJTS Jan (director) and van ARENBERG Charles-Louis (director)6 facts ▸
  • General meeting, 30-06-2015
  • Director resignation, BOSQUET Marc (director)
  • Director appointment, BENIJTS Jan (director)
  • General meeting, 14-12-2015
  • Director resignation, VANACKERE Steven (director)
  • Director appointment, van ARENBERG Charles-Louis (director)
2015
22-09
State Gazette act Appointment: BCVBA RSM InterAudit (statutory auditor)
Permanent representatives: Patricia Kindt and Bernard de Grand Ry · Statutes amendment5 facts ▸
  • General meeting, 30/06/2015
  • Statutes amendment
  • Auditor appointment, BCVBA RSM InterAudit (statutory auditor)
  • Permanent representative, Patricia Kindt
  • Permanent representative, Bernard de Grand Ry
2014
03-11
State Gazette act Resignations: KIPS Johan, CASTEELS Minne and 6 others
Appointments: DECRAMER Marc, JPTR BVBA and 9 others · Permanent representatives: PEETERS JEF and ILUNGA KALENGA Oly · Reappointments: CASTEELS Minne, DE GREEF Piet and 5 others42 facts ▸
  • General meeting, 08/04/2014
  • Statutes amendment
  • General meeting, 05/09/2013
  • Director resignation, KIPS Johan (director)
  • Director appointment, DECRAMER Marc (director)
  • General meeting, 25/04/2014
  • Director appointment, JPTR BVBA (director)
  • Director appointment, JPTR BVBA (managing director)
  • Director appointment, JPTR BVBA (directeur général)
  • Permanent representative, PEETERS JEF
  • Director resignation, CASTEELS Minne (administrateur délégué a.i.)
  • General meeting, 29/04/2014
  • +30 further facts in this act
10-04
State Gazette act Withdrawals: Prof. Jean-François Denef (member) and M. D. Lambrechts (member)
Resignations: Prof. Jean-François Denef, M. D. Lambrechts and Prof. G. Mannaert · Appointments: Prof. M. Casteels, Dr. K. Ilunga and 2 others · Permanent representative: Dr. K. Ilunga25 facts ▸
  • General meeting, 30/01/2014
  • Board meeting, 30/01/2014
  • Member resignation, Prof. Jean-François Denef
  • Director resignation, Prof. Jean-François Denef (director)
  • Member resignation, M. D. Lambrechts
  • Director resignation, M. D. Lambrechts (director)
  • Power of attorney, M. Hugues Delescaille
  • Power of attorney, Sylvie Deconinck
  • Power of attorney, Anouk Hermans
  • Power of attorney, Régis Panisi
  • Power of attorney, Marcos Lamin-Busschots
  • Director resignation, M. D. Lambrechts (afgevaardigd bestuurder)
  • +13 further facts in this act
2013
22-03
State Gazette act Resignations: DE BIE Myriam, VAN CAMPENHOUDT Marc and GIANELLO Pierre
Appointments: ILUNGA KALENGA Oly, LAMBRECHTS Dirk and MAZY Renaud · Reappointments: DURANT Guy (director) and KUNSCH Christian (director)13 facts ▸
  • General meeting, 21-01-2013
  • Board meeting, 21-01-2013
  • Director resignation, DE BIE Myriam (bestuurder, afgevaardigde bestuurder en secretaris)
  • Director resignation, VAN CAMPENHOUDT Marc (bestuurder, afgevaardigde bestuurder en secretaris)
  • Director resignation, GIANELLO Pierre (director)
  • Director appointment, ILUNGA KALENGA Oly (director)
  • Director appointment, LAMBRECHTS Dirk (director)
  • Director appointment, MAZY Renaud (director)
  • Director appointment, ILUNGA KALENGA Oly (afgevaardigde bestuurder)
  • Director appointment, LAMBRECHTS Dirk (afgevaardigde bestuurder)
  • Director appointment, LAMBRECHTS Dirk (secretary)
  • Director reappointment, DURANT Guy (director)
  • +1 further facts in this act
2012
06-09
State Gazette act Reappointments: DE GREEF PIET (director) and VERHAEGHE JAN (director)
Appointment: DGST Partners -: Bedrijfsrevisoren (statutory auditor) · Permanent representatives: Etienne DEBAEKE, Luk OSTYN and Michaël DERIDDER7 facts ▸
  • General meeting, 23-05-2012
  • Director reappointment, DE GREEF PIET (director)
  • Director reappointment, VERHAEGHE JAN (director)
  • Auditor appointment, DGST Partners -: Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Etienne DEBAEKE
  • Permanent representative, Luk OSTYN
  • Permanent representative, Michaël DERIDDER
2010
09-08
State Gazette act Resignations: SCHOLTES, Jean-Louis, VLEUGELS, Arthur and 2 others
Appointments: CASTEELS, Maria Reinhilde, GIANELLO, Pierre and 5 others · Reappointments: DENEF, Jean-François, MELIN, Jacques and 3 others18 facts ▸
  • General meeting, 25-11-2009
  • Director resignation, SCHOLTES, Jean-Louis (director)
  • Director resignation, VLEUGELS, Arthur (director)
  • Director resignation, WAER, Mark (director)
  • Director appointment, CASTEELS, Maria Reinhilde (director)
  • Director appointment, GIANELLO, Pierre (director)
  • Director appointment, KIPS, Johan (director)
  • Director reappointment, DENEF, Jean-François (director)
  • Director reappointment, MELIN, Jacques (director)
  • Director reappointment, DE BIE, Myriam (director)
  • Director reappointment, VAN CAMPENHOUDT, Marc (director)
  • Director reappointment, MANNAERTS, Guy (director)
  • +6 further facts in this act
2009
20-08
State Gazette act Appointments: Prof. DENEF Jean-François (chair) and Prof. MANNAERTS Guy (onder voorzitter)
2 facts ▸
  • Director appointment, Prof. DENEF Jean-François (chair)
  • Director appointment, Prof. MANNAERTS Guy (onder voorzitter)
2005
11-07
State Gazette act Admissions: Borghgraef Roger, Casteels Rik and 8 others
Appointments: Dr M. Van Campenhoudt (director) and Dr M. De Bie (director) · Statutes amendment · Incorporation date18 facts ▸
  • General meeting, 18/05/2005
  • Statutes amendment
  • Statutes amendment
  • Incorporation date, 07/03/1986
  • Member admission, Borghgraef Roger
  • Member admission, Casteels Rik
  • Member admission, Haxhe, Jean-Jacques
  • Member admission, Lavenne, Franz
  • Member admission, Masson, Pierre
  • Member admission, Meulders, Michel
  • Member admission, Moulart, Jean
  • Member admission, Peers Jan
  • +6 further facts in this act
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.An act published in both Dutch and French appears here once.
54 of 55 acts read
About the unread acts

Of the 55 Belgian State Gazette acts we know for this company, 54 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
28 directors, last change in 2026
Benijts Jan
Director · since 01-01-2026
Current
SEBASTIAN SPENCER EMERGENCY CARE SYSTEMS
Administrateur directeur médical et administrateur délégué · since 01-01-2024 · Private limited company · perm. rep.: Sebastian Spencer
Current
P. Fontaine
Administrateur délégué unique · since 05-07-2023
Current
MUSTIN Vincent
Director · since 24-06-2022
Current
Philippe Lambrecht
Director · since 24-06-2022
Current
Yombi Jean Cyr
Administrateur effectif · since 26-04-2021
Current
22 other directors
Charles-Louis d'Arenberg
Director · since 16-12-2019
Current
QALY-CO
Director · since 15-02-2019 · Foreign entity · perm. rep.: Verplancke Lieve
Current
STRATEGIC MANAGEMENT ASSOCIATES
Director · since 15-02-2019 · Private limited company · perm. rep.: van Lierde Bruno
Current
GREGOIRE Donatienne
Director · since 09-06-2018
Current
Paul De Leyn
Director · since 09-06-2018
Current
WELTENS Caroline
Director · since 09-06-2018
Current
GORGEMANS Arnaud
Director · since 17-10-2016
Current
van Arenberg Charles-Louis
Vice president · since 14-12-2015
Current
FORELUX
Vice-chair · since 15-02-2019 · Public limited company · perm. rep.: d' Arenberg Charles-Louis
Not recently confirmed
HSMC
Managing director · since 15-02-2019 · Private limited company · perm. rep.: Fontaine Peter
Not recently confirmed
Meeûs Y.
Director · since 15-02-2019
Not recently confirmed
sprl scintimag
Administrateur délégué unique représentant · since 15-02-2019 · Legal entity
Not recently confirmed
HAINE Emmanuel
Director · since 29-04-2014
Not recently confirmed
Jef Peeters
Secrétaire du conseil d'administration · since 30-06-2015
Not recently confirmed
ILUNGA KALENGA Oly
Director · since 01-01-2013
Not recently confirmed
G. Durant
Vice président ad intérim · since 30-01-2014
Not recently confirmed
G. Mannaert
Président ad intérim · since 10-04-2014
Not recently confirmed
K. Ilunga
Secretary · since 30-01-2014
Not recently confirmed
M. Casteels
Administrateur délégué ad intérim · since 30-01-2014
Not recently confirmed
CASTEELS, Maria Reinhilde
Director · since 25-11-2009
Not recently confirmed
Dr M. De Bie
Managing director · since 11-07-2005
Not recently confirmed
Dr M. Van Campenhoudt
Managing director · since 11-07-2005
Not recently confirmed
01-01-2026 Benijts Jan: Appointed as Director
01-01-2026 Benijts Jan: Appointed as Director
01-01-2026 DR. Jan BENIJTS, UROLOOG: Resigned as Director
01-01-2026 DR. Jan BENIJTS, UROLOOG: Resigned as Director
27-06-2025 GORGEMANS Arnaud: Appointed as Director
Full history in the Timeline (280 changes) →
Not every act has been read: a resignation may be missing here
1 of this company's 55 Belgian State Gazette acts has not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Ukkel · 4 establishment units since 1986
seat establishment All 4 establishment units on the map
Ground area
11.8 ha
Building footprint
2.0 ha
Volume, LiDAR
225,247 m³
4 parcels, Brussels, Flanders, Wallonia · tallest building 29.7 m, ±6 floors. Linked by address, not a title deed.
39 companies at this address See who is registered here
4 establishment units
Europa Ziekhuizen VZW / Sint Elisabeth
De Frélaan 206, 1180 UkkelNACE 85110
since 19862.138.443.390
sint-michiel
Linthoutstraat 150, 1040 EtterbeekNACE 85110
since 19992.139.063.596
Bella Vita Medical Center
Allée André Delvaux 16, 1410 WaterlooHuman health activities
since 20162.366.764.366
REVALIDATIEZIEKENHUIS INKENDAAL
Inkendaalstraat 1, 1602 Sint-Pieters-LeeuwHuman health activities
since 20242.366.766.544
4 parcels
Flanders 1 (25%) Wallonia 1 (25%) Brussels 2 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
23089E0216/00G000 Flanders 8.9 ha 1 · 1.1 ha 19.1 m · 2 fl.
21612C0286/00Y015 Brussels 1.7 ha 1 · 913 m² 20.4 m · 5 fl.
21005A0499/00X007 Brussels 9,174 m² 1 · 6,824 m² 29.7 m · 6 fl.
25762G0500/00A002
ProtectedArchitectural ensemble
Wallonia 2,623 m² 1 · 659 m² 15.1 m · 3 fl.
Linked by address, not proof of ownership
Good to know
4 of 4 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage: expect extra rules on renovation or sale.

Statutory auditor

1 auditor
Callens, Vandelanotte & Theunissen SRLCurrent
Réviseur d'entreprise
25-06-2024 → present
Show 5 earlier auditors
BDO
Statutory auditor · represented by Michaël Delbeke
succeeded by Callens, Vandelanotte & Theunissen SRL in 2024
22-02-2023 → 25-06-2024
DGST & Partners - Bedrijfsrevisoren
Statutory auditor
succeeded by RSM INTERAUDIT in 2015
23-05-2012 → 22-09-2015
JEH Invest
Auditor
succeeded by DGST & Partners - Bedrijfsrevisoren in 2012
13-05-2009 → 23-05-2012
RSM INTERAUDIT
Auditor
succeeded by Société BDO in 2023
22-09-2015 → 22-02-2023
Société BDO
Commissaire réviseur d'entreprise · represented by Michaël Delbeke
succeeded by Callens, Vandelanotte & Theunissen SRL in 2024
22-02-2023 → 25-06-2024

Articles of association

Purpose
Buiten elk winstoogmerk, kwaliteitsvolle en toegankelijke zorg garanderen. Tot de concrete activiteiten die dit doel helpen bereiken, behoren onder meer: -het aanwenden van…
Full purpose

Buiten elk winstoogmerk, kwaliteitsvolle en toegankelijke zorg garanderen. Tot de concrete activiteiten die dit doel helpen bereiken, behoren onder meer: -het aanwenden van projecten en het gebruik van alle activiteiten voor medische en niet-medische zorgverlening en ondersteuning van organisatorische aard; -het beheer van de hospitalisatiediensten, de poliklinieken, de medisch-technische diensten en andere instellingen of diensten voor de gezondheidszorg; -het beheer van alle sociale organen, namelijk kinderdagverblijven, nuttig voor de verwezenlijking van bovengenoemd doel. Zij volbrengt alle handelingen die hiermee een rechtstreeks of onrechtstreeks verband houden. In het kader van dit doel zal zij haar medewerking verlenen aan de taken van opleiding en vorming van personeel en van medisch onderzoek. De vereniging mag haar maatschappelijk doel te allen tijde realiseren op de wijze die haar het meest aangepast lijkt. Zij kan alle handelingen verrichten die, van welke aard of omvang ook, geheel of deels en op het even welke wijze op haar maatschappelijk doel betrekking hebben, inbegrepen de bijkomende commerciële activiteiten waarvan de opbrengst integraal bestemd is voor de verwezenlijking van het belangeloze doel.

Structure & network

Connections & network

95 connected companies
Linked via shared directors
Show 91 more companies with a shared director
Compagnie Immobilière de Belgique
via Philippe Lambrecht · Chair and day-to-day manager
former→
former→
former→
former→
AGORIA
Shared director
→
→
→
ASSOCIATIE KU Leuven
Shared director
→
Atomos
Shared director
→
AXA BELGIUM
Shared director
→
BAXTER
Shared director
→
BERM
Shared director
→
bonsai
Shared director
→
→
BVDL
Shared director
→
CAPRICORN ICT ARKIV
Shared director
→
→
→
CREDE
Shared director
→
Damiaan Oostende
Shared director
→
de Duve Institute
Shared director
→
DEME CONCESSIONS
Shared director
→
Envia Waas
Shared director
→
EPM ACADEMY
Shared director
→
EPSYLON
Shared director
→
EPSYMMO
Shared director
→
ETHIAS
Shared director
→
Fairtrade Belgium
Shared director
→
Familiehulp
Shared director
→
Familiehulp Goed Wonen
Shared director
→
→
Fondation Saint - Luc
Shared director
→
→
GEO SOLUTIONS
Shared director
→
→
HD GESTION
Shared director
→
HOSPITAL LOGISTICS
Shared director
→
Imelda
Shared director
→
L'Economie Populaire
Shared director
→
→
MATERIALISE
Shared director
→
MercurHosp
Shared director
→
→
→
nexuzhealth
Shared director
→
NYXOAH
Shared director
→
→
QUEST FOR GROWTH
Shared director
→
Sodexo Belgium SA
Shared director
→
SOPARTEC
Shared director
→
TEMPORA
Shared director
→
→
→
TRAVIE
Shared director
→
Valisana
Shared director
→
VEOLIA NV-SA
Shared director
→
→
Westlandia VZW
Shared director
→
Z.org KU Leuven
Shared director
→
Zorgnet-Icuro
Shared director
→

Public money · subsidies and aid

Flemish government

2022 to 2025 · 4 entries · 32,908 EUR awarded · 32,908 EUR paid
Year Entries awardedpaid
2025 1 4,194 EUR4,194 EUR
2024 1 6,672 EUR6,672 EUR
2023 1 9,338 EUR9,338 EUR
2022 1 12,704 EUR12,704 EUR
Schemes
Vlaamse ondersteuningspremie (VOP) voor werkgevers (uitdovend stelsel)
4 entries · 32,908 EUR · 32,908 EUR paid · Departement Werk en Sociale Economie

Federal government

2024 to 2025 · 2 entries · 377,036 EUR in total
Year Department Transactions Amount
2025 FOD Volksgezondheid 1 306,405 EUR
2024 FOD Volksgezondheid 1 70,631 EUR
Budget allocations
Subsidie ziekenwagendiensten
1 entry · 306,405 EUR
Toelagen dringende geneeskundige hulpverlening
1 entry · 70,631 EUR

Wallonia-Brussels Federation

2024 to 2025 · 2 entries · 19,549 EUR in total
Year Entries paid
2025 1 10,945 EUR
2024 1 8,604 EUR
Budget allocations
Sub. - PV : Dépistage surdité
1 entry · 8,604 EUR

European Union, budget

2024 to 2025 · 3 entries · 141,074 EUR in total
Year Entries awarded
2025 1 58,715 EUR
2024 2 82,359 EUR
Projects
SERVICE MÉDICAL: FRAIS DE FONCTIONNEMENT DES ÉQUIPEMENTS ET DU LABORATOIRE
Social and Mobility · 16-09-2024 to 31-03-2025 · 82,359 EUR
MEDICAL SERVICE: EQUIPMENT AND SUPPLIES
Social and Mobility · 12-03-2025 to 10-09-2025 · 58,715 EUR

Recognitions · licences · registrations

Food safety, FASFC

2 sites
Etterbeek2.139.063.596
2 permissions
Toelating · Melkkeuken (bereiding - distributie maaltijden) · since 29-05-2006
Toelating · Ziekenhuis (bereiding - distributie maaltijden) · since 29-05-2006
Ukkel2.138.443.390
2 permissions
Toelating · Melkkeuken (bereiding - distributie maaltijden) · since 01-01-2006
Toelating · Ziekenhuis (bereiding - distributie maaltijden) · since 01-01-2006

Care and welfare

1 service
Cliniques de l'Europe - Europa Ziekenhuizen
Care and Health agency · live
Vaccin voorraadplaats

Legal Entity Identifier

5493002AB3IKT4N0IV94
live in the LEI register

Similar companies · same sector, comparable size

Of 157 companies in sector 86101 we hold annual accounts for 81. 44 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formNon-profit association
Founded07-03-1986
Fiscal year end31-12
Activities, NACEBEL 2025
86101Human health activities
86220Specialist medical practice
Contact
Phone 02 373 46 11Etterbeek
Fax 02 373 49 86Etterbeek

Scores and ratios are computed by Checked and are not a credit decision.